Griffith University Clinical Trial Unit

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)1 trial
• Gout1 trial
• Idiopathic pulmonary fibrosis1 trial
• Systemic sclerosis (scleroderma)1 trial

Phase

• Phase 22 trials
• Phase 32 trials

Status

• Active, not recruiting2 trials
• Completed1 trial
• Recruiting1 trial

Lead sponsor

• LG Chem1 trial
• Mediar Therapeutics1 trial
• Novo Nordisk A/S1 trial
• Syndax Pharmaceuticals1 trial

Running trials

• Recruiting

  EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

  NCT07287670· Phase 2· Mediar Therapeutics· Source

  Contact: Gerald Tracey (principal investigator)

• Active, not recruiting

  MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

  NCT06132256· Phase 2· Syndax Pharmaceuticals· Source

• Active, not recruiting

  Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

  NCT04822181· Phase 3· Novo Nordisk A/S· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Systemic sclerosis (scleroderma)1 recruiting

Closed trials

• Completed

  Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients

  NCT05586971· Phase 3· LG Chem· Source